Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-01-27

AUTHORS

Emanuela Palmerini, Marco Gambarotti, Eric L Staals, Licciana Zanella, Gabriela Sieberova, Alessandra Longhi, Marilena Cesari, Stefano Bonarelli, Piero Picci, Pietro Ruggieri, Marco Alberghini, Stefano Ferrari

ABSTRACT

BackgroundDermatofibrosarcoma protuberans (DFSP) is a relatively common soft-tissue tumor. A more aggressive appearing fibrosarcoma may arise in DFSP, changing its biological behavior. CD34 and apolipoprotein-D are highly expressed in DFSP, but their prognostic significance is uncertain.MethodsDFSP and fibrosarcomatous-DFSP (FS-DFSP) patients referred to our institute between 1982 and 2009 were identified. Fibrosarcomatous changes, expression of CD34 and apolipoprotein-D were evaluated.Results40 patients, (median age 43 years, 55% males) were identified. Tumor was located in the limbs in 60%, in the trunk in 40%. Thirty-seven patients had localized and 3 had metastatic disease. Thirteen (32%) patients were FS-DFSP. All but one underwent surgery with adequate surgical margins in 72%. 7 FS-DFSP received also radiotherapy (RT). Chemotherapy was administered to 3 patients with FS-DFSP. With a median follow-up of 49 months, the 5-OS was 90%. Local recurrence rate was 23%: 42% FS-DFSP, 15% DFSP. Metastases developed in three FS-DFSP patients. The 5-year EFS was 70% in localized patients. Histology (DFSP 75% vs. FS-DFSP 52%, p = 0.002), surgical margins (adequate 74% vs. inadequate 55%, p = 0.02), site (limb 47% vs. trunk 100%), CD34 expression (CD34 positive: 70% vs. CD34 negative: 33%, p = 0.05), and apolipoprotein-D expression (Apo-D positive: 73% vs. Apo-D negative: 33%, p = 0.02) influenced the 5-year EFS, whereas sex, use of RT or number of previous surgical treatments did not.ConclusionsPatients with DFSP have a high survival probability. Site, adequate surgical margins, presence of the fibrosarcomatous component, lack of CD34 expression and apolipoprotein-D influence outcome. More... »

PAGES

4

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/2045-3329-2-4

DOI

http://dx.doi.org/10.1186/2045-3329-2-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009776160

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22587823


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Chemotherapy, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Chemotherapy, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Palmerini", 
        "givenName": "Emanuela", 
        "id": "sg:person.01210215667.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210215667.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Surgical Pathology, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Surgical Pathology, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gambarotti", 
        "givenName": "Marco", 
        "id": "sg:person.01334463454.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334463454.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Orthopaedic Surgery, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Orthopaedic Surgery, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Staals", 
        "givenName": "Eric L", 
        "id": "sg:person.01324444267.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324444267.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Surgical Pathology, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Surgical Pathology, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zanella", 
        "givenName": "Licciana", 
        "id": "sg:person.01116130114.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116130114.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Surgical Pathology, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Surgical Pathology, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sieberova", 
        "givenName": "Gabriela", 
        "id": "sg:person.0575525747.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575525747.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chemotherapy, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Chemotherapy, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Longhi", 
        "givenName": "Alessandra", 
        "id": "sg:person.01167151157.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167151157.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chemotherapy, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Chemotherapy, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cesari", 
        "givenName": "Marilena", 
        "id": "sg:person.0711754347.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711754347.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chemotherapy, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Chemotherapy, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bonarelli", 
        "givenName": "Stefano", 
        "id": "sg:person.01107220166.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107220166.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Oncologic Research, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Laboratory of Oncologic Research, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Picci", 
        "givenName": "Piero", 
        "id": "sg:person.0753274552.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753274552.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Orthopaedic Surgery, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Orthopaedic Surgery, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ruggieri", 
        "givenName": "Pietro", 
        "id": "sg:person.01267530665.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267530665.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Surgical Pathology, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Surgical Pathology, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alberghini", 
        "givenName": "Marco", 
        "id": "sg:person.01127763410.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127763410.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chemotherapy, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Chemotherapy, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferrari", 
        "givenName": "Stefano", 
        "id": "sg:person.013005321532.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013005321532.44"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/978-1-4615-6121-7_7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000751434", 
          "https://doi.org/10.1007/978-1-4615-6121-7_7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/modpathol.3800971", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003479183", 
          "https://doi.org/10.1038/modpathol.3800971"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-01-27", 
    "datePublishedReg": "2012-01-27", 
    "description": "BackgroundDermatofibrosarcoma protuberans (DFSP) is a relatively common soft-tissue tumor. A more aggressive appearing fibrosarcoma may arise in DFSP, changing its biological behavior. CD34 and apolipoprotein-D are highly expressed in DFSP, but their prognostic significance is uncertain.MethodsDFSP and fibrosarcomatous-DFSP (FS-DFSP) patients referred to our institute between 1982 and 2009 were identified. Fibrosarcomatous changes, expression of CD34 and apolipoprotein-D were evaluated.Results40 patients, (median age 43 years, 55% males) were identified. Tumor was located in the limbs in 60%, in the trunk in 40%. Thirty-seven patients had localized and 3 had metastatic disease. Thirteen (32%) patients were FS-DFSP. All but one underwent surgery with adequate surgical margins in 72%. 7 FS-DFSP received also radiotherapy (RT). Chemotherapy was administered to 3 patients with FS-DFSP. With a median follow-up of 49 months, the 5-OS was 90%. Local recurrence rate was 23%: 42% FS-DFSP, 15% DFSP. Metastases developed in three FS-DFSP patients. The 5-year EFS was 70% in localized patients. Histology (DFSP 75% vs. FS-DFSP 52%, p = 0.002), surgical margins (adequate 74% vs. inadequate 55%, p = 0.02), site (limb 47% vs. trunk 100%), CD34 expression (CD34 positive: 70% vs. CD34 negative: 33%, p = 0.05), and apolipoprotein-D expression (Apo-D positive: 73% vs. Apo-D negative: 33%, p = 0.02) influenced the 5-year EFS, whereas sex, use of RT or number of previous surgical treatments did not.ConclusionsPatients with DFSP have a high survival probability. Site, adequate surgical margins, presence of the fibrosarcomatous component, lack of CD34 expression and apolipoprotein-D influence outcome.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/2045-3329-2-4", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1046367", 
        "issn": [
          "2045-3329"
        ], 
        "name": "Clinical Sarcoma Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "2"
      }
    ], 
    "keywords": [
      "adequate surgical margins", 
      "surgical margins", 
      "expression of CD34", 
      "FS-DFSP", 
      "fibrosarcomatous change", 
      "CD34 expression", 
      "common soft tissue tumors", 
      "local recurrence rate", 
      "previous surgical treatment", 
      "use of radiotherapy", 
      "soft tissue tumors", 
      "BackgroundDermatofibrosarcoma protuberans", 
      "Results40 patients", 
      "underwent surgery", 
      "Thirteen patients", 
      "metastatic disease", 
      "surgical treatment", 
      "prognostic significance", 
      "recurrence rate", 
      "DFSP patients", 
      "fibrosarcomatous component", 
      "patients", 
      "dermatofibrosarcoma protuberans", 
      "influence outcomes", 
      "radiotherapy", 
      "biological behavior", 
      "CD34", 
      "DFSP", 
      "apolipoproteins", 
      "tumors", 
      "protuberans", 
      "expression", 
      "survival probability", 
      "ConclusionsPatients", 
      "chemotherapy", 
      "surgery", 
      "metastasis", 
      "higher survival probability", 
      "histology", 
      "fibrosarcoma", 
      "EFS", 
      "disease", 
      "months", 
      "limb", 
      "outcomes", 
      "sex", 
      "treatment", 
      "trunk", 
      "changes", 
      "margin", 
      "significance", 
      "sites", 
      "Institute", 
      "rate", 
      "lack", 
      "presence", 
      "EF", 
      "use", 
      "number", 
      "components", 
      "probability", 
      "behavior"
    ], 
    "name": "Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans", 
    "pagination": "4", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009776160"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/2045-3329-2-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22587823"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/2045-3329-2-4", 
      "https://app.dimensions.ai/details/publication/pub.1009776160"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_564.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/2045-3329-2-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/2045-3329-2-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/2045-3329-2-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/2045-3329-2-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/2045-3329-2-4'


 

This table displays all metadata directly associated to this object as RDF triples.

213 TRIPLES      21 PREDICATES      89 URIs      79 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/2045-3329-2-4 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Nf8106524fed64035a103b67bdf2585f8
4 schema:citation sg:pub.10.1007/978-1-4615-6121-7_7
5 sg:pub.10.1038/modpathol.3800971
6 schema:datePublished 2012-01-27
7 schema:datePublishedReg 2012-01-27
8 schema:description BackgroundDermatofibrosarcoma protuberans (DFSP) is a relatively common soft-tissue tumor. A more aggressive appearing fibrosarcoma may arise in DFSP, changing its biological behavior. CD34 and apolipoprotein-D are highly expressed in DFSP, but their prognostic significance is uncertain.MethodsDFSP and fibrosarcomatous-DFSP (FS-DFSP) patients referred to our institute between 1982 and 2009 were identified. Fibrosarcomatous changes, expression of CD34 and apolipoprotein-D were evaluated.Results40 patients, (median age 43 years, 55% males) were identified. Tumor was located in the limbs in 60%, in the trunk in 40%. Thirty-seven patients had localized and 3 had metastatic disease. Thirteen (32%) patients were FS-DFSP. All but one underwent surgery with adequate surgical margins in 72%. 7 FS-DFSP received also radiotherapy (RT). Chemotherapy was administered to 3 patients with FS-DFSP. With a median follow-up of 49 months, the 5-OS was 90%. Local recurrence rate was 23%: 42% FS-DFSP, 15% DFSP. Metastases developed in three FS-DFSP patients. The 5-year EFS was 70% in localized patients. Histology (DFSP 75% vs. FS-DFSP 52%, p = 0.002), surgical margins (adequate 74% vs. inadequate 55%, p = 0.02), site (limb 47% vs. trunk 100%), CD34 expression (CD34 positive: 70% vs. CD34 negative: 33%, p = 0.05), and apolipoprotein-D expression (Apo-D positive: 73% vs. Apo-D negative: 33%, p = 0.02) influenced the 5-year EFS, whereas sex, use of RT or number of previous surgical treatments did not.ConclusionsPatients with DFSP have a high survival probability. Site, adequate surgical margins, presence of the fibrosarcomatous component, lack of CD34 expression and apolipoprotein-D influence outcome.
9 schema:genre article
10 schema:isAccessibleForFree true
11 schema:isPartOf N8a0a3732d01141f28eb2d9bd9213ce56
12 Nc2f2455fc2c04d98ac9236fd850ef9f6
13 sg:journal.1046367
14 schema:keywords BackgroundDermatofibrosarcoma protuberans
15 CD34
16 CD34 expression
17 ConclusionsPatients
18 DFSP
19 DFSP patients
20 EF
21 EFS
22 FS-DFSP
23 Institute
24 Results40 patients
25 Thirteen patients
26 adequate surgical margins
27 apolipoproteins
28 behavior
29 biological behavior
30 changes
31 chemotherapy
32 common soft tissue tumors
33 components
34 dermatofibrosarcoma protuberans
35 disease
36 expression
37 expression of CD34
38 fibrosarcoma
39 fibrosarcomatous change
40 fibrosarcomatous component
41 higher survival probability
42 histology
43 influence outcomes
44 lack
45 limb
46 local recurrence rate
47 margin
48 metastasis
49 metastatic disease
50 months
51 number
52 outcomes
53 patients
54 presence
55 previous surgical treatment
56 probability
57 prognostic significance
58 protuberans
59 radiotherapy
60 rate
61 recurrence rate
62 sex
63 significance
64 sites
65 soft tissue tumors
66 surgery
67 surgical margins
68 surgical treatment
69 survival probability
70 treatment
71 trunk
72 tumors
73 underwent surgery
74 use
75 use of radiotherapy
76 schema:name Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans
77 schema:pagination 4
78 schema:productId N8bb9bfd7b5e04c60a2fd23404089a5f6
79 Nd2ac75d6af84484c98532a10c5b0eea2
80 Ndfa3c1aff8c44b078adfd0f1eec09b51
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009776160
82 https://doi.org/10.1186/2045-3329-2-4
83 schema:sdDatePublished 2022-09-02T15:55
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher N7007775b868b4c9ab4123cbafc06d18a
86 schema:url https://doi.org/10.1186/2045-3329-2-4
87 sgo:license sg:explorer/license/
88 sgo:sdDataset articles
89 rdf:type schema:ScholarlyArticle
90 N016a472516d04b77b9fd0f51c262a55f rdf:first sg:person.01127763410.33
91 rdf:rest N04ddc2d197054c4da88bd834339f4796
92 N02f97e49cc374b638a16b9ea21043d8f rdf:first sg:person.0575525747.67
93 rdf:rest N23a93512d2d5498f8b7821b018ae39eb
94 N04ddc2d197054c4da88bd834339f4796 rdf:first sg:person.013005321532.44
95 rdf:rest rdf:nil
96 N0b1a20441db04b36bd302f94da362545 rdf:first sg:person.01107220166.13
97 rdf:rest N29a0a3eb88534f5fb8e0eeeeebb1cd28
98 N0e77dc006f4941748f9fef67243a8618 rdf:first sg:person.01267530665.46
99 rdf:rest N016a472516d04b77b9fd0f51c262a55f
100 N1a3a62a1ea9d4f5590640a9f38de8e38 rdf:first sg:person.0711754347.80
101 rdf:rest N0b1a20441db04b36bd302f94da362545
102 N23a93512d2d5498f8b7821b018ae39eb rdf:first sg:person.01167151157.23
103 rdf:rest N1a3a62a1ea9d4f5590640a9f38de8e38
104 N29a0a3eb88534f5fb8e0eeeeebb1cd28 rdf:first sg:person.0753274552.44
105 rdf:rest N0e77dc006f4941748f9fef67243a8618
106 N41b568e4a8d4441eac2223f087d33aec rdf:first sg:person.01334463454.00
107 rdf:rest N96b465ce1abd4145aa6ff78c92fc7d9f
108 N7007775b868b4c9ab4123cbafc06d18a schema:name Springer Nature - SN SciGraph project
109 rdf:type schema:Organization
110 N7adb4c041d3d452f8cf3a6bb92040e72 rdf:first sg:person.01116130114.25
111 rdf:rest N02f97e49cc374b638a16b9ea21043d8f
112 N8a0a3732d01141f28eb2d9bd9213ce56 schema:issueNumber 1
113 rdf:type schema:PublicationIssue
114 N8bb9bfd7b5e04c60a2fd23404089a5f6 schema:name pubmed_id
115 schema:value 22587823
116 rdf:type schema:PropertyValue
117 N96b465ce1abd4145aa6ff78c92fc7d9f rdf:first sg:person.01324444267.96
118 rdf:rest N7adb4c041d3d452f8cf3a6bb92040e72
119 Nc2f2455fc2c04d98ac9236fd850ef9f6 schema:volumeNumber 2
120 rdf:type schema:PublicationVolume
121 Nd2ac75d6af84484c98532a10c5b0eea2 schema:name doi
122 schema:value 10.1186/2045-3329-2-4
123 rdf:type schema:PropertyValue
124 Ndfa3c1aff8c44b078adfd0f1eec09b51 schema:name dimensions_id
125 schema:value pub.1009776160
126 rdf:type schema:PropertyValue
127 Nf8106524fed64035a103b67bdf2585f8 rdf:first sg:person.01210215667.35
128 rdf:rest N41b568e4a8d4441eac2223f087d33aec
129 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
130 schema:name Medical and Health Sciences
131 rdf:type schema:DefinedTerm
132 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
133 schema:name Clinical Sciences
134 rdf:type schema:DefinedTerm
135 sg:journal.1046367 schema:issn 2045-3329
136 schema:name Clinical Sarcoma Research
137 schema:publisher Springer Nature
138 rdf:type schema:Periodical
139 sg:person.01107220166.13 schema:affiliation grid-institutes:grid.419038.7
140 schema:familyName Bonarelli
141 schema:givenName Stefano
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107220166.13
143 rdf:type schema:Person
144 sg:person.01116130114.25 schema:affiliation grid-institutes:grid.419038.7
145 schema:familyName Zanella
146 schema:givenName Licciana
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116130114.25
148 rdf:type schema:Person
149 sg:person.01127763410.33 schema:affiliation grid-institutes:grid.419038.7
150 schema:familyName Alberghini
151 schema:givenName Marco
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127763410.33
153 rdf:type schema:Person
154 sg:person.01167151157.23 schema:affiliation grid-institutes:grid.419038.7
155 schema:familyName Longhi
156 schema:givenName Alessandra
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167151157.23
158 rdf:type schema:Person
159 sg:person.01210215667.35 schema:affiliation grid-institutes:grid.419038.7
160 schema:familyName Palmerini
161 schema:givenName Emanuela
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210215667.35
163 rdf:type schema:Person
164 sg:person.01267530665.46 schema:affiliation grid-institutes:grid.419038.7
165 schema:familyName Ruggieri
166 schema:givenName Pietro
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267530665.46
168 rdf:type schema:Person
169 sg:person.013005321532.44 schema:affiliation grid-institutes:grid.419038.7
170 schema:familyName Ferrari
171 schema:givenName Stefano
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013005321532.44
173 rdf:type schema:Person
174 sg:person.01324444267.96 schema:affiliation grid-institutes:grid.419038.7
175 schema:familyName Staals
176 schema:givenName Eric L
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324444267.96
178 rdf:type schema:Person
179 sg:person.01334463454.00 schema:affiliation grid-institutes:grid.419038.7
180 schema:familyName Gambarotti
181 schema:givenName Marco
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334463454.00
183 rdf:type schema:Person
184 sg:person.0575525747.67 schema:affiliation grid-institutes:grid.419038.7
185 schema:familyName Sieberova
186 schema:givenName Gabriela
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575525747.67
188 rdf:type schema:Person
189 sg:person.0711754347.80 schema:affiliation grid-institutes:grid.419038.7
190 schema:familyName Cesari
191 schema:givenName Marilena
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711754347.80
193 rdf:type schema:Person
194 sg:person.0753274552.44 schema:affiliation grid-institutes:grid.419038.7
195 schema:familyName Picci
196 schema:givenName Piero
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753274552.44
198 rdf:type schema:Person
199 sg:pub.10.1007/978-1-4615-6121-7_7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000751434
200 https://doi.org/10.1007/978-1-4615-6121-7_7
201 rdf:type schema:CreativeWork
202 sg:pub.10.1038/modpathol.3800971 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003479183
203 https://doi.org/10.1038/modpathol.3800971
204 rdf:type schema:CreativeWork
205 grid-institutes:grid.419038.7 schema:alternateName Chemotherapy, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy
206 Laboratory of Oncologic Research, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy
207 Orthopaedic Surgery, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy
208 Surgical Pathology, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy
209 schema:name Chemotherapy, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy
210 Laboratory of Oncologic Research, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy
211 Orthopaedic Surgery, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy
212 Surgical Pathology, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy
213 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...